Givinostat conditionally approved to treat patients with Duchenne muscular dystrophy (DMD).
In a significant development for patients with Duchenne muscular dystrophy (DMD), the Medicines and...
Santhera Pharmaceuticals announces that the Department of Health of Hong Kong, China, has approved AGAMREE® (vamorolone) for use in patients aged 4 years and...